The rate control, anticoagulation therapy, and electrophysiology/antiarrhythmic medication pathway for the management of atrial fibrillation and atrial flutter.
Atrial fibrillation is the most common cardiac rhythm disturbance encountered in clinical practice. Recent guidelines for the management of atrial fibrillation are complex and do not include the management of atrial flutter.To bridge the gap between currently available guidelines and patient management, we have developed a unique, simple, yet comprehensive pathway for the management of atrial fibrillation and atrial flutter. The pathway has been designed with the acronym RACE (rate control, anticoagulation therapy, and electrophysiology/antiarrhythmic medication) to reflect the 3 main components in patient management.This model is designed to mandate and then markedly improve adherence to the published American College of Cardiology, the American Heart Association and the European Society of Cardiology guidelines.
Herzog
Eyal
E
Division of Cardiology, St. Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, New York 10025, USA. eherzog@chpnet.org
Fischer
Avi
A
Steinberg
Jonathan S
JS